dipyridamole has been researched along with thromboplastin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hollmén, A; Kärkölä, P; Nuutinen, LS; Pihlajaniemi, R; Saarela, E | 1 |
| Brozna, JP; Carson, SD; Horan, M | 1 |
| Anderson, M; Dewar, P; Fleming, LB; Hacking, PM; Morley, AR; Murray, S; Swinney, J; Taylor, RM; Uldall, PR; Wardle, EN | 1 |
| Perlick, E | 1 |
| Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C | 1 |
| Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L | 1 |
| Christ, G; Huber, K; Kopp, CW; Maurer, G; Minar, E; Priglinger, U; Probst, P; Steiner, S | 1 |
| Zhou, H | 1 |
2 trial(s) available for dipyridamole and thromboplastin
| Article | Year |
|---|---|
A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection.
Topics: Biopsy; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Survival; Chromium Radioisotopes; Clinical Trials as Topic; Dipyridamole; Graft Rejection; Half-Life; Histocompatibility Testing; Humans; Kidney; Kidney Transplantation; Placebos; Platelet Adhesiveness; Prednisone; Radiography; Renal Artery; Thromboplastin; Transplantation, Homologous | 1974 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Stenosis; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Factor Xa; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Lipoproteins; Male; Middle Aged; Statistics as Topic; Stents; Thromboplastin; Thrombosis; Ticlopidine; Time Factors; Warfarin | 2003 |
6 other study(ies) available for dipyridamole and thromboplastin
| Article | Year |
|---|---|
The effect of dipyridamole on the thrombocyte count and bleeding tendency in open-heart surgery.
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation; Blood Platelets; Cardiopulmonary Bypass; Dipyridamole; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Heart Valve Diseases; Hemostasis, Surgical; Humans; Male; Middle Aged; Postoperative Complications; Thrombocytopenia; Thromboplastin | 1977 |
Dipyridamole inhibits O2- release and expression of tissue factor activity by peripheral blood monocytes stimulated with lipopolysaccharide.
Topics: Biological Transport; Cells, Cultured; Depression, Chemical; Dipyridamole; Endotoxins; Fibrinolytic Agents; Glucose; Humans; Inflammation; Leukocytes, Mononuclear; Lipopolysaccharides; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate; Thromboplastin | 1990 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nucleosides; Papaverine; Plasminogen; Serine; Sulfinpyrazone; Thromboplastin; Thrombosis | 1968 |
Antiplatelet agents in tissue factor-induced blood coagulation.
Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin | 2001 |
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2003 |
Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Topics: Adrenergic Antagonists; Antiphospholipid Syndrome; Cell Separation; Dilazep; Dipyridamole; Gene Expression; Humans; Immunoglobulin G; Monocytes; Platelet Aggregation Inhibitors; RNA, Messenger; Theophylline; Thromboplastin | 2004 |